Want to see TATYY full AI Analyst Report?
TATYY Stock Chart & Stats
$30.21
-$0.46(-1.52%)
At close: 4:00 PM EDT
$30.21
-$0.46(-1.52%)
Day’s Range― - ―
52-Week Range$17.53 - $30.51
Previous CloseN/A
Volume301.00
Average Volume (3M)17.00
Market Cap
$3.30B
Enterprise Value$3.39K
Total Cash (Recent Filing)$344.02M
Total Debt (Recent Filing)$1.29B
Price to Earnings (P/E)25.2
Beta0.53
Next Earnings
Nov 05, 2026EPS Estimate
1.11Next Dividend Ex-DateN/A
Dividend Yield3.33%
Share Statistics
EPS (TTM)0.89
Shares Outstanding111,362,500
10 Day Avg. Volume0
30 Day Avg. Volume17
Financial Highlights & Ratios
PEG Ratio0.20
Price to Book (P/B)1.02
Price to Sales (P/S)0.81
P/FCF Ratio13.12
Enterprise Value/Market Cap<0.01
Enterprise Value/Revenue<0.01
Enterprise Value/Gross Profit>-0.01
Enterprise Value/Ebitda<0.01
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)1.96
Revenue Forecast (FY)$2.69B
Bulls Say, Bears Say
Bulls Say
Recurring Specialty Ingredient ModelBeing incorporated into customer formulations can create recurring demand across production cycles and make switching less attractive. The mix of functional ingredients and application support also supports value-based pricing and a durable position with food and beverage manufacturers.
CP Kelco Integration And SynergiesSmooth integration without customer disruption reduces execution risk while the expanded cross-selling pipeline provides a route to future revenue synergies. Delivering the cost target one year early also demonstrates tangible operational discipline and can support margins over the medium term.
Specialty Solutions And Productivity MomentumGrowth in the new-business pipeline and new-product revenue indicates continuing demand for Tate & Lyle’s reformulation and functional ingredient capabilities. Productivity delivery adds internal funding capacity, helping offset cost pressure while supporting investment in higher-value solutions.
Bears Say
Higher Leverage After AcquisitionThe sharp increase in debt has reduced financial flexibility compared with prior years and raises the sensitivity of profits to weaker operating performance. Higher borrowings also increase financing commitments, limiting the company’s room to absorb prolonged softness or pursue further investment.
Underlying Regional Trading WeaknessUnderlying declines across major regions show that reported growth is partly dependent on acquisition contribution rather than broad-based organic momentum. Weakness in sweeteners and softer demand could weigh on volume recovery and make margin improvement harder if competitive pressure persists.
Inconsistent Cash ConversionCash conversion below target indicates that accounting earnings are not yet translating consistently into deployable cash. Higher inventory and extended customer terms tie up funds, potentially constraining debt reduction, dividends, and investment until working-capital performance normalizes.
Tate & Lyle News
TATYY FAQ
What was Tate & Lyle’s price range in the past 12 months?
Tate & Lyle lowest stock price was $17.53 and its highest was $30.51 in the past 12 months.
What is Tate & Lyle’s market cap?
Tate & Lyle’s market cap is $3.30B.
When is Tate & Lyle’s upcoming earnings report date?
Tate & Lyle’s upcoming earnings report date is Nov 05, 2026 which is in 43 days.
How were Tate & Lyle’s earnings last quarter?
Tate & Lyle released its earnings results on May 21, 2026. The company reported $1.031 earnings per share for the quarter, beating the consensus estimate of $0.838 by $0.193.
Is Tate & Lyle overvalued?
According to Wall Street analysts Tate & Lyle’s price is currently Overvalued.
Does Tate & Lyle pay dividends?
Tate & Lyle pays a Semiannually dividend of $0.71 which represents an annual dividend yield of 3.33%. See more information on Tate & Lyle dividends here
What is Tate & Lyle’s EPS estimate?
Tate & Lyle’s EPS estimate is 1.11.
How many shares outstanding does Tate & Lyle have?
Tate & Lyle has 111,362,500 shares outstanding.
What happened to Tate & Lyle’s price movement after its last earnings report?
Tate & Lyle reported an EPS of $1.031 in its last earnings report, beating expectations of $0.838. Following the earnings report the stock price went down -2.855%.
Which hedge fund is a major shareholder of Tate & Lyle?
Currently, no hedge funds are holding shares in TATYY
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Tate & Lyle Stock Smart Score
Neutral
1
2
3
4
5
6
7
8
9
10
Technicals
SMA
Positive
20 days / 200 days
Momentum
23.05%
12-Months-Change
Fundamentals
Return on Equity
3.33%
Trailing 12-Months
Asset Growth
0.39%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
Tate & Lyle
Tate & Lyle PLC, along with its subsidiaries, offers a diverse portfolio of ingredients and specialized solutions catering to the food, beverage, and other industrial sectors. Its global footprint spans the United States, the United Kingdom, continental European countries, and other international markets. The company's operations are structured into three primary divisions: Food & Beverage Solutions, Sucralose, and Primary Products. Its extensive product line includes texturizers, nutritive sweeteners like high fructose corn syrup and dextrose, health and wellness components, and stabilizers. Additionally, Tate & Lyle provides industrial starches for applications in paper, packaging, and adhesives, as well as acidulants such as citric acid. The firm also deals in commodities, supplying corn gluten feed and meal for animal nutrition, corn oil, and ethanol. Beyond its core product offerings, the company manages treasury and insurance businesses, and invests in research and development services. Established in 1903, Tate & Lyle PLC maintains its headquarters in London, UK.
TATYY Company Deck
TATYY Earnings Call
Q4 2026
0:00 / 0:00
Earnings Call Sentiment|Neutral
Neutral — The call balances clear strategic and operational progress (successful CP Kelco integration, early cross-selling wins, productivity and cost synergies delivered ahead of plan, stronger pipeline and a resilient margin/healthy balance sheet) against near-term trading and cash-flow headwinds (like-for-like revenue/EBITDA declines, regional softness in Europe and Latin America, a delayed bio-gums benefit, below-target cash conversion and one-off exceptional charges). Management presents a cautious but constructive outlook for modest revenue growth and H2-weighted volume recovery while acknowledging risks from tariffs, geopolitical uncertainty and timing of certain savings.View all TATYY earnings summariesTechnical Analysis
Ownership Overview
―
Insiders
0.02% Mutual Funds
― Other Institutional Investors
99.98% Public Companies and
Individual Investors